Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Praxis Precision Medicines (PRAX) Change in Cash: 2019-2024

Historic Change in Cash for Praxis Precision Medicines (PRAX) over the last 6 years, with Dec 2024 value amounting to $134.1 million.

  • Praxis Precision Medicines' Change in Cash fell 133.56% to -$7.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$19.1 million, marking a year-over-year decrease of 128.30%. This contributed to the annual value of $134.1 million for FY2024, which is 581.09% up from last year.
  • As of FY2024, Praxis Precision Medicines' Change in Cash stood at $134.1 million, which was up 581.09% from $19.7 million recorded in FY2023.
  • Praxis Precision Medicines' Change in Cash's 5-year high stood at $251.8 million during FY2020, with a 5-year trough of -$157.5 million in FY2021.
  • In the last 3 years, Praxis Precision Medicines' Change in Cash had a median value of $19.7 million in 2023 and averaged $25.4 million.
  • Its Change in Cash has fluctuated over the past 5 years, first surged by 837.25% in 2020, then crashed by 162.55% in 2021.
  • Yearly analysis of 5 years shows Praxis Precision Medicines' Change in Cash stood at $251.8 million in 2020, then slumped by 162.55% to -$157.5 million in 2021, then spiked by 50.67% to -$77.7 million in 2022, then skyrocketed by 125.34% to $19.7 million in 2023, then surged by 581.09% to $134.1 million in 2024.